Clinical Trial Update: Evaluation of Combined Sensitising and Hypomethylating Therapy Outcomes in AML PDX

View source ↗

Summary

A recruiting clinical trial evaluating a combined sensitising and hypomethylating therapy for acute myeloid leukemia using patient-derived xenograft (PDX) model…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Clinical Hub for Interventional Research (CHOIR) | Conditions: AML - Acute Myeloid Leukemia | Status: RECRUITING